Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators, particularly targeting 5-HT6 and 5-HT7 receptors. It shows potential in the development of treatments for neurological disorders such as Alzheimer's disease, schizophrenia, and depression. Its fluorinated structure enhances blood-brain barrier penetration, making it valuable in CNS drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity of novel psychoactive compounds.